Report on operations in the year ended April 30, 2004

Report on operations in the year ended April 30, 2004 · Profit after taxes increased to SEK 248 M (234). Earnings per share before dilution in-creased to SEK 7.63 (7.29) and after dilution to SEK 7.63 (7.14). · Operating profit amounted to SEK 306 M (323) and the operating margin was 11 percent (12). · Cash flow after investments rose sharply to SEK 363 M (288). · Order bookings rose 2 percent to SEK 3,262 M (3,186). At fixed exchange rates, order bookings increased 12 percent. Order bookings in the fourth quarter were SEK 1,119 M (974), up 15 percent. · The order backlog at April 30, 2004 amounted to SEK 2,728 M (2,411), a record high level. · Net sales rose 4 percent to SEK 2,900 M (2,781). At fixed exchange rates, net sales in-creased 14 percent. · The Board proposes that the Annual General Meeting provides authorization for buy-back of shares in Elekta AB corresponding to a maximum of 10 percent of the total number of shares outstanding. For full version, please see enclosed PDF file. For additional information, contact: Peter Ejemyr, Group VP Corporate Communications, Elekta AB (publ) Tel. +46-8-587 254 00 or +46-733-611 000 Further information on Elekta is available at: www.elekta.com ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2004/06/15/20040615BIT20750/wkr0006.pdf Reports on operations in the year ended April 30, 2004

About Us

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com

Subscribe

Documents & Links